4th Quarter - Report

AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION for AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION

Firm
Client
Income
—
Expenses
$274,307
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Lobby against House (HR 2092) and Senate (S1278) legislation to repeal the tax on indoor tanning services.

LobbyistCovered position, as disclosed
SHAWN FRIESEN —
KATIE JONES —
JENNIFER MASCHO —
CHRISTINE O'CONNOR —
WHITNEY TYLER —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2092 (112th)

Health Issues HCR

Lobby Congress regarding ongoing prescription drug shortage crisis and device reclassification - Food and Drug Administration Safety and Innovation Act (S. 3187) Lobby in support of House (HR 1676) and Senate action requesting the FDA examine the current classification of indoor tanning beds. Support the United States Preventive Services Task Force (USPSTF) Transparency and Accountability Act of 2012 (HR 5998) which recognizes the role of specialty physicians in providing expert guidance for developing and updating preventive health recommendations.

LobbyistCovered position, as disclosed
SHAWN FRIESEN —
KATIE JONES —
JENNIFER MASCHO —
CHRISTINE O'CONNOR —
WHITNEY TYLER —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 1676 (112th), S. 3187 (112th), H.R. 5998 (112th)

Medicare/Medicaid MMM

Support legislation to eliminate the Independent Payment Advisory Board (HR 452, HR 5) & (S 2118) Lobby Congress on enacting a permanent repeal to the Medicare sustainable growth rate (SGR) Lobby Congress on proposed legislation to repeal in-office ancillary and physician services for anatomic pathology services, oppose inclusion of language in HR 8 Support legislation to increase residency slots for Graduate Medical Education (HR 6352)

LobbyistCovered position, as disclosed
SHAWN FRIESEN —
KATIE JONES —
JENNIFER MASCHO —
CHRISTINE O'CONNOR —
WHITNEY TYLER —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5 (112th), H.R. 8 (112th), H.R. 452 (112th), H.R. 6352 (112th)

Medical/Disease Research/Clinical Labs MED

Support legislation to increase skin cancer research within the National Institutes of Health (HR 5716).

LobbyistCovered position, as disclosed
SHAWN FRIESEN —
KATIE JONES —
JENNIFER MASCHO —
CHRISTINE O'CONNOR —
WHITNEY TYLER —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5716 (112th)

Torts TOR

Support legislation to enact medical liability reform (HR 5).

LobbyistCovered position, as disclosed
SHAWN FRIESEN —
KATIE JONES —
JENNIFER MASCHO —
CHRISTINE O'CONNOR —
WHITNEY TYLER —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.